Congenital muscular dystrophy: from muscle to brain.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27576556)

Published in Ital J Pediatr on August 31, 2016

Authors

Raffaele Falsaperla1, Andrea D Praticò2,3, Martino Ruggieri2, Enrico Parano4, Renata Rizzo2, Giovanni Corsello5, Giovanna Vitaliti1, Piero Pavone6

Author Affiliations

1: Unit of Pediatrics and Pediatric Emergency, University Hospital "Policlinico-Vittorio Emanuele", Catania, Italy.
2: Section of Pediatrics and Child Neuropsychiatry, Department of Clinical and Experimental Sciences, University of Catania, Catania, Italy.
3: Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy.
4: National Research Council-Section of Catania, Catania, Italy.
5: Department of Maternal and Child Health, University of Palermo, Palermo, Italy.
6: Unit of Pediatrics and Pediatric Emergency, University Hospital "Policlinico-Vittorio Emanuele", Catania, Italy. ppavone@unict.it.

Articles cited by this

An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature (1998) 3.86

Diagnostic criteria for Walker-Warburg syndrome. Am J Med Genet (1989) 3.74

Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome. Am J Hum Genet (2002) 3.09

Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan. Brain (2007) 2.88

POMT2 mutations cause alpha-dystroglycan hypoglycosylation and Walker-Warburg syndrome. J Med Genet (2005) 2.80

Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan. Hum Mol Genet (2003) 2.69

Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan. Am J Hum Genet (2001) 2.66

Targeting nuclear RNA for in vivo correction of myotonic dystrophy. Nature (2012) 2.63

Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum Mol Genet (2001) 2.45

Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population. Brain (2009) 2.38

Congenital muscular dystrophies with defective glycosylation of dystroglycan: a population study. Neurology (2009) 2.33

Congenital progressive muscular dystrophy of the Fukuyama type - clinical, genetic and pathological considerations. Brain Dev (1981) 2.11

The myotonic dystrophies: molecular, clinical, and therapeutic challenges. Lancet Neurol (2012) 2.01

Neuroimaging manifestations and classification of congenital muscular dystrophies. AJNR Am J Neuroradiol (1998) 1.71

Hydrocephalus, lissencephaly, ocular abnormalities and congenital muscular dystrophy. A Warburg syndrome variant? Neuropediatrics (1986) 1.61

Walker-Warburg syndrome. Orphanet J Rare Dis (2006) 1.59

Hydrocephaly, congenital retinal nonattachment, and congenital falciform fold. Am J Ophthalmol (1978) 1.57

Evidence-based guideline summary: evaluation, diagnosis, and management of congenital muscular dystrophy: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Issues Review Panel of the American Association of Neuromuscular & Electrodiagnostic Medicine. Neurology (2015) 1.49

Diagnostic approach to the congenital muscular dystrophies. Neuromuscul Disord (2014) 1.40

Localization of a gene for Fukuyama type congenital muscular dystrophy to chromosome 9q31-33. Nat Genet (1993) 1.24

Genetic epidemiology of congenital muscular dystrophy in a sample from north-east Italy. Hum Genet (1996) 1.24

Worldwide distribution and broader clinical spectrum of muscle-eye-brain disease. Hum Mol Genet (2003) 1.17

The ever-expanding spectrum of congenital muscular dystrophies. Ann Neurol (2012) 1.15

Defective glycosylation in muscular dystrophy. Lancet (2002) 1.10

Congenital muscular dystrophy. Part I: a review of phenotypical and diagnostic aspects. Arq Neuropsiquiatr (2009) 1.10

The floppy infant: evaluation of hypotonia. Pediatr Rev (2009) 1.00

Cerebro-oculo-muscular syndrome: a variant of Fukuyama congenital cerebromuscular dystrophy. Clin Neuropathol (1982) 0.97

Novel POMGnT1 mutations define broader phenotypic spectrum of muscle-eye-brain disease. Neurogenetics (2007) 0.96

Congenital muscular dystrophy, brain malformation and ocular problems (muscle, eye and brain disease) in two German families. Eur J Pediatr (1984) 0.92

Ocular findings in Fukuyama type congenital muscular dystrophy. Brain Dev (1989) 0.92

Ophthalmological findings of muscular dystrophies: a survey of 53 cases. J Pediatr Ophthalmol Strabismus (1979) 0.89

Congenital muscular dystrophies with cognitive impairment. A population study. Neurology (2010) 0.88

114th ENMC International Workshop on Congenital Muscular Dystrophy (CMD) 17-19 January 2003, Naarden, The Netherlands: (8th Workshop of the International Consortium on CMD; 3rd Workshop of the MYO-CLUSTER project GENRE). Neuromuscul Disord (2003) 0.81

Clinical, radiological, and genetic survey of patients with muscle-eye-brain disease caused by mutations in POMGNT1. Pediatr Neurol (2014) 0.80

Neonatal hypotonia. Clin Perinatol (2015) 0.80

Congenital muscular dystrophies: clinical review and proposed classification. Pediatr Neurol (1995) 0.80

Advances in Muscular Dystrophies. JAMA Neurol (2015) 0.78

Congenital muscular dystrophy with adducted thumbs, ptosis, external ophthalmoplegia, mental retardation and cerebellar hypoplasia: a novel form of CMD. Neuromuscul Disord (2002) 0.78

Congenital myopathies and muscular dystrophies. Neurol Clin (2014) 0.77

Congenital muscular dystrophy: correlation of muscle biopsy and clinical features. Pediatr Neurol (1994) 0.77

Prevalence of congenital muscular dystrophy in Italy: a population study. Neurology (2015) 0.77

[Etiology of congenital muscular dystrophy (Fukuyama type)]. Nihon Rinsho (1977) 0.76

Long-term survival in a patient with muscle-eye-brain disease. Neurol Sci (2015) 0.76